Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD
Public ClinicalTrials.gov record NCT06215144. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3 Randomized Double-Blind Placebo Controlled Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR in Pediatric Subjects With Attention-Deficit/Hyperactivity Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the efficacy and safety of NRCT-101SR compared to placebo in subjects 13-17 years of age with ADHD
Study identification
- NCT ID
- NCT06215144
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 95 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 13 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 25, 2024 (Actual)
- Primary completion
- Oct 10, 2025 (Actual)
- Completion
- Nov 6, 2025 (Actual)
- Last update posted
- Jan 15, 2026
2024 – 2025
United States locations
- U.S. sites
- 13
- U.S. states
- 8
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Advanced Research Center, Inc | Anaheim | California | 92805 | — |
| Accel Research Sites - Lakeland Clinical Research Unit | Lakeland | Florida | 33803 | — |
| Accel Research Sites Network - Maitland | Maitland | Florida | 32751 | — |
| Bio-Medical Research LLC | Miami | Florida | 33144 | — |
| CenExel ACMR Atlanta Center for Medical Research | Atlanta | Georgia | 30331 | — |
| iResearch Atlanta | Decatur | Georgia | 30030 | — |
| CenExel iRS - iResearch Savannah | Savannah | Georgia | 31405 | — |
| DelRicht Research | New Orleans | Louisiana | 70155 | — |
| DelRicht Research | Prairieville | Louisiana | 70769 | — |
| Boston Clinical Trials Llc | Boston | Massachusetts | 02131 | — |
| Vector Clinical Trials | Las Vegas | Nevada | 89128 | — |
| Coastal Carolina Research Center - North Charleston | North Charleston | South Carolina | 29405 | — |
| Epic Medical Research - DeSoto | DeSoto | Texas | 75115 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06215144, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 15, 2026 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06215144 live on ClinicalTrials.gov.